In this study, RACGAP1 expression was screened using related public databases, which confirmed that RACGAP1 is a key and clinically related driving factor promoting the expression of NE markers in progressive PCa, providing a new and powerful basis for treating NEPC. This evidence concerns the gene RACGAP1 and posterior cortical atrophy.